全文：
Overview
This article presents a detailed protocol for the in vivo differentiation of human embryonic stem cells (hESCs) and the subsequent analysis of their tissue-specific fates. The method involves creating a cell pellet from genetically tagged hESCs and implanting it under the kidney capsule of an immunocompromised mouse for differentiation.
Key Study Components
Area of Science
- Regenerative Medicine
- Stem Cell Biology
- In Vivo Differentiation
Background
- Human embryonic stem cells have potential in regenerative therapies.
- Understanding the fate of hESCs is crucial for developing cell-based therapies.
- In vivo studies provide insights into tissue-specific differentiation.
- Ethical approvals are essential for research involving human cells and animal models.
Purpose of Study
- To develop a protocol for tracking the differentiation of hESCs in vivo.
- To analyze the fate of genetically tagged hESCs after implantation.
- To provide a reliable method for studying teratoma formation and differentiation.
Methods Used
- Preparation of hESC cultures and creation of cell pellets.
- Surgical implantation of cell pellets under the kidney capsule of mice.
- Monitoring differentiation over 8 to 12 weeks.
- Harvesting and analyzing teratomas using immunohistochemistry.
Main Results
- Successful differentiation of hESCs into various germ layers observed.
- Teratomas formed in vivo, providing a model for studying differentiation.
- Immunohistochemical analysis confirmed the fate of tagged cells.
- The protocol can be used to assess the differentiation potential of different hESC lines.
Conclusions
- The protocol offers a valuable tool for regenerative medicine research.
- In vivo tracking of hESCs enhances understanding of their differentiation.
- Results support the potential of hESCs in therapeutic applications.
What is the significance of using genetically tagged hESCs?
Genetically tagged hESCs allow for tracking and analyzing their differentiation and fate in vivo.
How long does the differentiation process take?
The differentiation process typically takes 8 to 12 weeks.
What type of analysis is performed on the harvested teratomas?
Immunohistochemistry is used to analyze the fate of tagged cells within the teratomas.
What ethical approvals are required for this research?
Approval from the Institutional Animal Care and Use Committee and the Stem Cell Research Oversight Committee is required.
Can this protocol be used for different hESC lines?
Yes, the protocol can be adapted to assess the differentiation potential of various hESC lines.
繁體中文
